Literature DB >> 30215267

Short Communication: Dried Blood Spots Stored at Room Temperature Should Not Be Used for HIV Incidence Testing.

Anna L Eisenberg1, Eshan U Patel2, Zoe R Packman2, Reinaldo E Fernandez2, Estelle Piwowar-Manning2, Erica L Hamilton3, Catherine MacPhail4, James Hughes5,6, Audrey Pettifor7,8,9,10, Esper G Kallas11, Michael P Busch12,13, Gary Murphy14, Thomas C Quinn1, Susan H Eshleman2, Oliver Laeyendecker1.   

Abstract

The limiting antigen (LAg)-avidity assay is a serologic assay used for cross-sectional HIV incidence testing. We compared the results obtained with the LAg-avidity assay using dried blood spot (DBS) samples stored at room temperature (18°C-25°C) or stored frozen at -80°C with results obtained from matched plasma samples. Matched DBS and plasma samples (306 paired samples) were collected in the HIV Prevention Trials Network (HPTN) 068 trial in South Africa (2012-2014). The DBS were stored at room temperature before testing. Matched DBS and plasma samples (100 paired samples) from the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) were collected in 2016 and were stored at -80°C. All DBS testing was performed in 2017. Differences in normalized optical density (ODn) were compared between matched DBS and plasma samples. For DBS samples stored at room temperature (HPTN 068), the average difference in ODn values for plasma versus DBS was 1.49 (95% confidence intervals [CI]: 1.36-1.62). In contrast, when DBS samples were stored at -80°C (CEPHIA), the average difference in ODn values for plasma versus DBS was -0.22 (95% CI: -0.32 to -0.13). DBS samples stored at room temperature should not be used for cross-sectional HIV incidence testing with the LAg-avidity assay.

Entities:  

Keywords:  dried blood spot; incidence testing; sample storage

Mesh:

Year:  2018        PMID: 30215267      PMCID: PMC6306669          DOI: 10.1089/AID.2018.0138

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

Review 1.  Use of filter paper for the collection and analysis of human whole blood specimens.

Authors:  J V Mei; J R Alexander; B W Adam; W H Hannon
Journal:  J Nutr       Date:  2001-05       Impact factor: 4.798

Review 2.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Authors:  Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

3.  Measuring the HIV/AIDS epidemic: approaches and challenges.

Authors:  Ron Brookmeyer
Journal:  Epidemiol Rev       Date:  2010-03-04       Impact factor: 6.222

4.  The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial.

Authors:  Audrey Pettifor; Catherine MacPhail; James P Hughes; Amanda Selin; Jing Wang; F Xavier Gómez-Olivé; Susan H Eshleman; Ryan G Wagner; Wonderful Mabuza; Nomhle Khoza; Chirayath Suchindran; Immitrude Mokoena; Rhian Twine; Philip Andrew; Ellen Townley; Oliver Laeyendecker; Yaw Agyei; Stephen Tollman; Kathleen Kahn
Journal:  Lancet Glob Health       Date:  2016-11-01       Impact factor: 26.763

5.  Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.

Authors:  Andrew F Longosz; Shruti H Mehta; Gregory D Kirk; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

6.  Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping.

Authors:  Susan C Aitken; Carole L Wallis; Wendy Stevens; Tobias Rinke de Wit; Rob Schuurman
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Sheila M Keating; Shelley N Facente; Elaine McKinney; Matthew A Price; Jeffrey N Martin; Susan Little; Frederick M Hecht; Esper G Kallas; Alex Welte; Michael P Busch; Gary Murphy
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

8.  Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

Authors:  Katherine E Schlusser; Christopher Pilcher; Esper G Kallas; Breno R Santos; Steven G Deeks; Shelley Facente; Sheila M Keating; Michael P Busch; Gary Murphy; Alex Welte; Thomas Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

9.  Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).

Authors:  Oliver Laeyendecker; Estelle Piwowar-Manning; Agnes Fiamma; Michal Kulich; Deborah Donnell; Deb Bassuk; Caroline E Mullis; Craig Chin; Priscilla Swanson; John Hackett; William Clarke; Mark Marzinke; Greg Szekeres; Glenda Gray; Linda Richter; Michel W Alexandre; Suwat Chariyalertsak; Alfred Chingono; David D Celentano; Stephen F Morin; Michael Sweat; Thomas Coates; Susan H Eshleman
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  9 in total
  1 in total

Review 1.  A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications.

Authors:  Joseph Kin-On Lau; Nicholas Murdock; Jeffrey Murray; Jessica Justman; Neil Parkin; Veronica Miller
Journal:  J Virus Erad       Date:  2022-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.